Free Republic

Don’t you want a president who is going to ensure the food your children eat isn’t filled with chemicals that are going to give them cancer and chronic disease?

Doctors in seven countries have started the world’s first patient trials of a new mRNA vaccine against lung cancer. The lung cancer vaccine, known as BNT116 and developed by Germany’s BioNTech, is designed to target non-small cell lung carcinoma (NSCLC), the most common type of lung cancer. Its goal is to eliminate cancer cells and, at the same time, prevent them from coming back by training the immune system to recognize these cancer cells and attack them. Unlike chemotherapy, the vaccine attacks the cancer cells and does not destroy healthy cells around them. Lung cancer is the most common cause...

A study led by investigators found that Manuka honey could potentially be an alternative, natural option for breast cancer prevention and treatment—particularly for estrogen receptor (ER)-positive breast cancer, the most common subtype of breast cancer that accounts for about 70–80% of all breast cancer cases. In preclinical experiments, researchers found: —Manuka honey significantly reduced tumor growth in mice with ER-positive breast cancer cells by 84% without affecting normal breast cells or causing major side effects. —Higher concentrations of Manuka honey led to a greater reduction in cancer cell growth. —Manuka honey reduced levels of signaling pathways that are upregulated in...

A study suggests that cannabis, the most commonly used illicit substance worldwide, is associated with an increased occurrence of head and neck cancer. A large, multicenter study revealed that adults with cannabis dependence, known as cannabis use disorder, are 3.5 to 5 times more likely to develop head and neck cancer than those who do not use the substance. Head and neck cancer, the sixth most common cancer in the world, includes several cancers, including cancer of the mouth, pharynx, larynx, oropharynx (tongue and tonsils and back wall of the throat) and adjacent salivary glands. The researchers discovered that those...

Researchers at Western University in Ontario, Canada have discovered a protein that can curb DNA damage. The breakthrough discovery could have practical applications in anything from developing cancer vaccines to creating drought-resistant crops. The researchers found the protein – called DdrC (DNA Damage Repair Protein C) – in a common bacterium named Deinococcus radiodurans. The protein has the incredible ability to withstand between 5,000 and 10,000 times the radiation that would kill a normal human cell. Lead researcher Robert Sczabla says that Deinococcus also stands out for its ability to repair DNA that’s already been damaged. He explained that while...

Patients with advanced kidney cancer are routinely given immune checkpoint inhibitors (ICIs) as first-line treatment. The CONTACT-03, phase 3 clinical trial tested the effects of giving ICIs again, as part of a standard second-line therapy. It is the first trial of its kind to compare a standard therapy alone (cabozantinib) to standard therapy plus an ICI (atezolizumab plus cabozantinib) in solid tumors that have progressed after first-line therapy with an ICI. Patients taking atezolizumab plus cabozantinib did not experience longer progression free survival or overall survival compared with those taking cabozantinib alone. An examination of subgroups of patients based on...

A shocking video circulating on social media has exposed staff members at a Knoxville, Tennessee dental office for mercilessly mocking a cancer patient's private diary while reading it aloud. The footage, which appears to have been recorded and shared online by a giggling employee, shows a staff member of Premier Dental Group of Knoxville reading passages from a patient's journal to nearby colleagues. The video shows employees laughing at the patient's thoughts on different treatment options and concerns about various procedures. The incident has sparked widespread outrage, with many condemning the dental practice and calling for a boycott, KVUE reported....

WASHINGTON (AP) — President Joe Biden is zeroing in on the policy goals closest to his heart now that he’s no longer seeking a second term and will visit New Orleans on Tuesday to promote his administration’s “moonshot” initiative aiming at dramatically reducing cancer deaths. The president and first lady Jill Biden will tour medical facilities, then, at Tulane University, will help announce $150 million in awards from the Advanced Research Projects Agency for Health. Those will support eight teams of researchers around the country working on ways to help surgeons more successfully remove tumors for people facing cancer. The...

Regular aspirin may help lower risk of colorectal cancer in people with greater lifestyle-related risk factors for the disease, according to a study. For the study, researchers analyzed the health data from 107,655 participants from the Nurses' Health Study and Health Professionals Follow-Up Study. They compared the colorectal cancer rates in those who took aspirin regularly with those who did not take aspirin regularly. Regular aspirin use was defined as either two or more standard dose (325 mg) tablets per week or daily low-dose (81 mg) aspirin. Study participants were followed starting from an average age of 49.4 years. Those...

Awful news. We also separately know from the work of eminent oncologist Prof Dalgleish & others that the covid vaccine is a likely carcinogen. Remember Pfizer have invested $43 billion in treating turbo cancers for a reason. We must remove these psychopathic entities. RIP Jane

Researchers have discovered that a diet free of the amino acid tryptophan can effectively halt the growth of liver cancer in mice. Their findings offer new insights for dietary-based cancer treatments and highlight the critical role of the tryptophan metabolite indole 3-pyruvate (I3P) in liver tumor development. Hepatocellular carcinoma (HCC) is the third-leading cause of cancer-related mortality worldwide, with limited options for effective treatment and a five-year survival rate of about 30%. The study shows that growth of liver cancers driven by the MYC oncogene is particularly dependent on tryptophan, which is converted into I3P as well as other metabolites....

Pancreatic cancer is a formidable disease, often diagnosed too late for effective treatment. However, new research represents a promising step toward identifying biological signals or biomarkers that may aid in early detection. By tracking changes in body composition and metabolism, researchers are working to identify high-risk patients who could benefit from selective screening for the disease. "If we catch them early, at stage 1A, their five-year survival rate can be as high as 80%," says Yan Bi, M.D., Ph.D. "Detecting the cancer earlier is the best way to improve survival." Dr. Bi teamed up with Derk Klatte, M.D., Ph.D. to...

The results of routine blood tests could be used to speed up cancer diagnosis among people with stomach pain or bloating, suggests a study. The study looked at data from more than 400,000 people aged 30 or older in the UK who had visited a GP due to stomach pain and more than 50,000 who had visited their GP due to bloating. Two thirds of this group had blood tests following their appointment. In the new study, the researchers found that people aged 60 or over who had gone to the GP with either stomach pain or bloating had a...

Nearly half of the nation's National Cancer Institute (NCI)-designated cancer centers required universal masking in key clinical areas during the winter 2023–2024 COVID-19 surge, according to a study by Tulane University researchers. Overall, 41.8% of these 67 centers required some universal masking, according to the study, which was published in JAMA Network Open. Further, 12 NCI-designated centers (18%) required universal masking in all areas. Masking policies were even more common in northeastern states and in centers with longer NCI designation, more funding and higher care rankings. Those with cancer face higher risks from COVID-19 infections, long COVID, infection-related delay of...

The US Food and Drug Administration has approved a blood test to be used for colorectal cancer screening among average-risk adults 45 and older. The maker of the test, Palo Alto, California-based biotechnology company Guardant Health, announced Monday that this is the first blood test to be approved by the FDA as a primary screening option for colorectal cancer, and it’s the first approved blood screening test for colorectal cancer that meets requirements for Medicare reimbursement. For patients with commercial insurance plans, the cost of the test may vary depending on their individual plan coverage. The list price for the...

Two reduced dose radiopharmaceutical therapy approaches for advanced stage metastatic castrate-resistant prostate cancer have been shown to be just as effective as the standard dose, according to research. Treatment with deescalated 225Ac-PSMA-617 or a cocktail therapy of 177Lu/225Ac-PSMA-617 resulted in similar median overall survival and prostate specific antigen (PSA) response rates as the standard 225Ac-PSMA-617 dose and was better-tolerated. The standard dose for 225Ac-PSMA targeted radiopharmaceutical alpha-therapy is 100 kBq per kilogram of body weight or an approximation of eight MBq. "Preliminary data has shown that reduced doses result in lower rates of dry mouth while still maintaining promising anti-tumor...

I first heard that ivermectin (IVM) has significant potential to treat cancer in an Epoch Times video interview featuring Dr. Kathleen Ruddy, who has partnered with the FLCCC (Front Line Covid-19 Critical Care Alliance) to research it. Recall that IVM is the same “horse dewormer” the FDA and others in the medical industrial complex went to great lengths to discourage as a Covid-19 treatment. In the video, Dr. Ruddy suggested why so little research is being done on it: “…the pharmaceutical industries were not going to invest in a $0.10 pill. If the pharmaceutical industries were not willing to do...

Is the legacy media and Big Pharma blocking research into the use of ivermectin as a cancer treatment? I first heard that ivermectin (IVM) has significant potential to treat cancer in an Epoch Times video interview featuring Dr. Kathleen Ruddy, who has partnered with the FLCCC (Front Line Covid-19 Critical Care Alliance) to research it. Recall that IVM is the same “horse dewormer” the FDA and others in the medical industrial complex went to great lengths to discourage as a Covid-19 treatment. In the video, Dr. Ruddy suggested why so little research is being done on it: “…the pharmaceutical industries...

A simple blood test that measures the number of lymphocytes, a type of white blood cell in the body, may predict whether people who have relapsed multiple myeloma are going to respond well to CAR-T immunotherapy, according to research. The paper found patients who had an increase in absolute lymphocyte count (ALC) during the first 15 days after receiving a CAR-T infusion had a higher chance of a complete response and better progression-free survival than patients with a lower ALC at day 15. Knowing the treatment may not work allows doctors to try other options more quickly. Multiple myeloma is...

After being down with a bout of COVID since late last week, President Biden made a televised speech to explain why he is dropping out of the 2024 race for the presidency. While his remarks have been described as "slurred" and "semi-coherent," a few points stood out. "I believe my record as president, my leadership in the world, my vision for America's future, all merited a second term," Biden said. "But nothing—nothing—can come in the way of saving our democracy. That includes personal ambition. So I decided the best way forward is to pass the torch to a new generation."...